Superworth

Milestone Pharmaceuticals EPS MIST

Diluted earnings per share by quarter and over the last twelve months, from 2018.

Last 12 months, to Jun 30, 2026
−$0.69
Latest quarter, Q2 FY26
−$0.21
Fiscal year 2025
−$0.79

Milestone Pharmaceuticals' earnings per share was −$0.69 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.21.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.79n/a
FY2024−$0.68n/a
FY2023−$1.39n/a
FY2022−$1.37n/a
FY2021−$1.02n/a
FY2020−$1.83n/a
FY2019−$19.63n/a
FY2018−$70.44n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.21n/a−$0.69
Q1 FY26−$0.20n/a−$0.68
Q4 FY25−$0.16n/a−$0.79
Q3 FY25−$0.12n/a−$0.82
Q2 FY25−$0.20n/a−$0.84
Q1 FY25−$0.31n/a−$0.78
Q4 FY24−$0.19n/a−$0.68
Q3 FY24−$0.14n/a−$0.81
Q2 FY24−$0.14n/a−$1.02
Q1 FY24−$0.21n/a−$1.25
Q4 FY23−$0.32n/a−$1.39
Q3 FY23−$0.35n/a−$1.38

Against its peers

Companies in Drug Manufacturers - General nearest Milestone Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
MISTMilestone Pharmaceuticals−$0.69
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Milestone Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.